McCormick & Company Incorporated (MKC-V)vsArcadia Biosciences Inc (RKDA)
MKC-V
McCormick & Company Incorporated
$47.89
+2.99%
CONSUMER DEFENSIVE · Cap: $13.14B
RKDA
Arcadia Biosciences Inc
$1.03
+3.00%
CONSUMER DEFENSIVE · Cap: $1.94M
Smart Verdict
WallStSmart Research — data-driven comparison
McCormick & Company Incorporated generates 149305% more annual revenue ($7.11B vs $4.76M). MKC-V leads profitability with a 23.1% profit margin vs -195.9%. MKC-V earns a higher WallStSmart Score of 74/100 (B).
MKC-V
Strong Buy74
out of 100
Grade: B
RKDA
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+73.6%
Fair Value
$272.31
Current Price
$47.89
$224.42 discount
Margin of Safety
+37.9%
Fair Value
$2.80
Current Price
$1.03
$1.77 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Earnings expanding 528.0% YoY
Every $100 of equity generates 24 in profit
Keeps 23 of every $100 in revenue as profit
Reasonable price relative to book value
16.7% revenue growth
Reasonable price relative to book value
Earnings expanding 28.5% YoY
Areas to Watch
Expensive relative to growth rate
Distress zone — elevated risk
Smaller company, higher risk/reward
Weak financial health signals
ROE of -323.1% — below average capital efficiency
Revenue declined 8.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : MKC-V
The strongest argument for MKC-V centers on P/E Ratio, EPS Growth, Return on Equity. Profitability is solid with margins at 23.1% and operating margin at 14.3%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : RKDA
The strongest argument for RKDA centers on Price/Book, EPS Growth.
Bear Case : MKC-V
The primary concerns for MKC-V are PEG Ratio, Altman Z-Score.
Bear Case : RKDA
The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
MKC-V profiles as a growth stock while RKDA is a turnaround play — different risk/reward profiles.
MKC-V carries more volatility with a beta of 0.64 — expect wider price swings.
MKC-V is growing revenue faster at 16.7% — sustainability is the question.
MKC-V generates stronger free cash flow (18M), providing more financial flexibility.
Bottom Line
MKC-V scores higher overall (74/100 vs 38/100), backed by strong 23.1% margins and 16.7% revenue growth. RKDA offers better value entry with a 37.9% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
McCormick & Company Incorporated
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.
Arcadia Biosciences Inc
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.
Visit Website →Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?